June 15 (Reuters) - Oncolys BioPharma Inc 4588.T :
* Says it signed a joint research agreement with a research
group of Graduate School of Medicine of Kyoto University
* Says the research agreement is for exploring the compound
to normalize cancer cells by activating RECK gene
Source text in Japanese: https://goo.gl/FMXyTZ
Further company Coverage: 4588.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))